Axsome Therapeutics, Inc. AXSM announced that the FDA has approved Symbravo (meloxicam and rizatriptan) for the acute ...

Axsome Therapeutics (NASDAQ:AXSM) has received FDA approval for its drug Symbravo for the acute treatment of migraine with or ...

People who live with narcolepsy — about ... GHB and criminally used as a date rape drug — has been sold under the brand name Xyrem after gaining FDA approval in 2002. In order to bring it ...

Shares in Axsome Therapeutics have rocketed on FDA ... approved in March 2019 and is administered as a nasal spray twice a week for four weeks. However, it has a broader label as unlike J&J's drug ...

The amount of people with MDD continues to increase every year. The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of MDD in those who have not ...

Ozempic is already widely used and was first FDA-approved in 2017 to treat type 2 diabetes. The medication — taken weekly by injection in the thigh, stomach or arm — is a brand name for ...

The new indications, approved Tuesday by the FDA, make Ozempic the most broadly indicated drug in its class, with the largest set of specific medical conditions that it may be prescribed to treat.

The antibody drug conjugate was approved for patients with unresectable or metastatic HER2-low or -ultralow breast cancer with disease progression after endocrine therapy. The Food and Drug ...

The Axsome management team will provide an overview of SYMBRAVO and anticipated commercial plans. The presenters will be available to answer questions at the end of the presentation. To access the ...

(Reuters) -The U.S. FDA ... of drugs known as GLP-1 receptor agonists and has the same active ingredient as its popular obesity treatment Wegovy. The U.S. Food and Drug Administration's approval ...

Researchers conducted a cross-sectional study examining obesity medication prescription trends and online search queries from July 2017 to February 2024. Prescriptions for FDA-approved medications ...